Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2010, Article ID 845975, 10 pages
http://dx.doi.org/10.1155/2010/845975
Review Article

Metalloproteinase Inhibitors: Status and Scope from Marine Organisms

1Marine Biochemistry Laboratory, Department of Chemistry, Pukyong National University, Busan 608-737, Republic of Korea
2Marine Bioprocess Research Center, Pukyong National University, Busan 608-737, Republic of Korea

Received 7 August 2010; Revised 1 October 2010; Accepted 28 October 2010

Academic Editor: Sanford I. Bernstein

Copyright © 2010 Noel Vinay Thomas and Se-Kwon Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Huxley-Jones, T.-K. Clarke, C. Beck, G. Toubaris, D. L. Robertson, and R. P. Boot-Handford, “The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio,” BMC Evolutionary Biology, vol. 7, article 63, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. G. Murphy and H. Nagase, “Progress in matrix metalloproteinase research,” Molecular Aspects of Medicine, vol. 29, no. 5, pp. 290–308, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M.-H. Lee and G. Murphy, “Matrix metalloproteinases at a glance,” Journal of Cell Science, vol. 117, no. 18, pp. 4015–4016, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Egeblad and Z. Werb, “New functions for the matrix metalloproteinases in cancer progression,” Nature Reviews Cancer, vol. 2, no. 3, pp. 161–174, 2002. View at Google Scholar · View at Scopus
  6. W. C. Parks, C. L. Wilson, and Y. S. López-Boado, “Matrix metalloproteinases as modulators of inflammation and innate immunity,” Nature Reviews Immunology, vol. 4, no. 8, pp. 617–629, 2004. View at Google Scholar · View at Scopus
  7. J. D. Mott and Z. Werb, “Regulation of matrix biology by matrix metalloproteinases,” Current Opinion in Cell Biology, vol. 16, no. 5, pp. 558–564, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. C. M. Overall and C. López-Otín, “Strategies for MMP inhibition in cancer: innovations for the post-trial era,” Nature Reviews Cancer, vol. 2, no. 9, pp. 657–672, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Zhang and S.-K. Kim, “Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects,” Marine Drugs, vol. 7, no. 2, pp. 71–84, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. Tallant, A. Marrero, and F. X. Gomis-Rüth, “Matrix metalloproteinases: fold and function of their catalytic domains,” Biochimica et Biophysica Acta, vol. 1803, no. 1, pp. 20–28, 2010. View at Publisher · View at Google Scholar · View at PubMed
  11. D. Bourboulia and W. G. Stetler-Stevenson, “Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion,” Seminars in Cancer Biology, vol. 20, no. 3, pp. 161–168, 2010. View at Publisher · View at Google Scholar · View at PubMed
  12. D. E. Gomez, D. F. Alonso, H. Yoshiji, and U. P. Thorgeirsson, “Tissue inhibitors of metalloproteinases: structure, regulation and biological functions,” European Journal of Cell Biology, vol. 74, no. 2, pp. 111–122, 1997. View at Google Scholar · View at Scopus
  13. E. Lambert, E. Dassé, B. Haye, and E. Petitfrère, “TIMPs as multifacial proteins,” Critical Reviews in Oncology/Hematology, vol. 49, no. 3, pp. 187–198, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. M. Wilhelm, I. E. Collier, B. L. Marmer, A. Z. Eisen, G. A. Grant, and G. I. Goldberg, “SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages,” Journal of Biological Chemistry, vol. 264, no. 29, pp. 17213–17221, 1989. View at Google Scholar · View at Scopus
  15. R. V. Ward, R. M. Hembry, J. J. Reynolds, and G. Murphy, “The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1,” Biochemical Journal, vol. 278, part 1, pp. 179–187, 1991. View at Google Scholar · View at Scopus
  16. A. Amour, C. G. Knight, A. Webster et al., “The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3,” FEBS Letters, vol. 473, no. 3, pp. 275–279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Williamson, M. D. Carr, T. A. Frenkiel, J. Feeney, and R. B. Freedman, “Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation,” Biochemistry, vol. 36, no. 45, pp. 13882–13889, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A. Yiotakis and V. Dive, “Third-generation MMP inhibitors: recent advances in the development of highly selective inhibitors,” in The Cancer Degradome, pp. 811–825, Springer, Amsterdam, The Netherlands, 2008. View at Google Scholar
  19. L. M. Coussens, B. Fingleton, and L. M. Matrisian, “Matrix metalloproteinase inhibitors and cancer: trials and tribulations,” Science, vol. 295, no. 5564, pp. 2387–2392, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Pavlaki and S. Zucker, “Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials,” Cancer and Metastasis Reviews, vol. 22, no. 2-3, pp. 177–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. M. Overall and C. P. Blobel, “In search of partners: linking extracellular proteases to substrates,” Nature Reviews Molecular Cell Biology, vol. 8, no. 3, pp. 245–257, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A.-C. Dublanchet, P. Ducrot, C. Andrianjara et al., “Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 16, pp. 3787–3790, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. U.-K. Seo, Y.-J. Lee, J.-K. Kim et al., “Large-scale and effective screening of Korean medicinal plants for inhibitory activity on matrix metalloproteinase-9,” Journal of Ethnopharmacology, vol. 97, no. 1, pp. 101–106, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K.-T. Ha, J.-K. Kim, S.-K. Kang et al., “Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma,” Pharmacological Research, vol. 50, no. 3, pp. 279–285, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Jain, “Marine life: new hope for cancer drugs,” Indian Journal of Cancer, vol. 46, no. 3, pp. 243–244, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. Judé, S. Roger, E. Martel et al., “Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers,” Progress in Biophysics and Molecular Biology, vol. 90, no. 1–3, pp. 299–325, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. A. Hansen, M. A. Harris, G. E. Pluhar et al., “Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease,” Journal of Nutritional Biochemistry, vol. 19, no. 2, pp. 101–108, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. I. Suzuki, M. Iigo, C. Ishikawa et al., “Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities,” International Journal of Cancer, vol. 73, no. 4, pp. 607–612, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Harris, R. A. Hansen, P. Vidsudhiphan et al., “Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 65, no. 1, pp. 23–29, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. B. Lødemel, W. Egge-Jacobsen, and R. L. Olsen, “Detection of TIMP-2-like protein in Atlantic cod (Gadus morhua) muscle using two-dimensional real-time reverse zymography,” Comparative Biochemistry and Physiology Part B, vol. 139, no. 2, pp. 253–259, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. R. P. González, A. Leyva, and M. O. Moraes, “Shark cartilage as source of antiangiogenic compounds: from basic to clinical research,” Biological and Pharmaceutical Bulletin, vol. 24, no. 10, pp. 1097–1101, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. É. Dupont, P. E. Savard, C. Jourdain et al., “Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis,” Journal of Cutaneous Medicine and Surgery, vol. 2, no. 3, pp. 146–152, 1998. View at Google Scholar · View at Scopus
  33. R. M. Bukowski, “AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma,” Expert Opinion on Investigational Drugs, vol. 12, no. 8, pp. 1403–1411, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. S.-H. Lee, Z.-J. Qian, and S.-K. Kim, “A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats,” Food Chemistry, vol. 118, no. 1, pp. 96–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Yamamoto and S. Takai, “Pharmacological implications of MMP-9 inhibition by ACE inhibitors,” Current Medicinal Chemistry, vol. 16, no. 11, pp. 1349–1354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Wang, Y. Cheng, F. Wang et al., “Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2,” Biomedicine and Pharmacotherapy, vol. 62, no. 5, pp. 297–302, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Fujita, Y. Nakao, S. Matsunaga et al., “Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai,” Journal of the American Chemical Society, vol. 125, no. 51, pp. 15700–15701, 2003. View at Publisher · View at Google Scholar · View at PubMed
  38. M. Fujita, Y. Nakao, S. Matsunaga et al., “Ancorinosides B-D, inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP), from the marine sponge Penares sollasi Thiele,” Tetrahedron, vol. 57, no. 7, pp. 1229–1234, 2001. View at Publisher · View at Google Scholar
  39. B. Ryu, Z.-J. Qian, and S.-K. Kim, “SHP-1, a novel peptide isolated from seahorse inhibits collagen release through the suppression of collagenases 1 and 3, nitric oxide products regulated by NF-κB/p38 kinase,” Peptides, vol. 31, no. 1, pp. 79–87, 2010. View at Publisher · View at Google Scholar · View at PubMed
  40. H. J. Moon, K. S. Park, M. J. Ku et al., “Effect of Costaria costata fucoidan on expression of matrix metalloproteinase-1 promoter, mRNA, and protein,” Journal of Natural Products, vol. 72, no. 10, pp. 1731–1734, 2009. View at Publisher · View at Google Scholar · View at PubMed
  41. M.-J. Joe, S.-N. Kim, H.-Y. Choi et al., “The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-1 in human dermal fibroblasts,” Biological and Pharmaceutical Bulletin, vol. 29, no. 8, pp. 1735–1739, 2006. View at Publisher · View at Google Scholar
  42. C.-S. Kong, Y. A. Kim, M.-M. Kim et al., “Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells,” Toxicology in Vitro, vol. 22, no. 7, pp. 1742–1748, 2008. View at Publisher · View at Google Scholar · View at PubMed
  43. J. Kim, Y. Cho, S. Park et al., “Antioxidants and inhibitor of matrix metalloproteinase-1 expression from leaves of Zostera marina L,” Archives of Pharmacal Research, vol. 27, no. 2, pp. 177–183, 2004. View at Publisher · View at Google Scholar
  44. R. N. Asolkar, K. C. Freel, P. R. Jensen et al., “Arenamides A-C, cytotoxic NFκB inhibitors from the marine actinomycete salinispora arenicola,” Journal of Natural Products, vol. 72, no. 3, pp. 396–402, 2009. View at Publisher · View at Google Scholar · View at PubMed
  45. K. S. Ahn, G. Sethi, T.-H. Chao et al., “Salinosporamide a (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB-regulated gene products,” Blood, vol. 110, no. 7, pp. 2286–2295, 2007. View at Publisher · View at Google Scholar · View at PubMed
  46. C. Liu, X. Li, Y. Li, Y. Feng, S. Zhou, and F. Wang, “Structural characterisation and antimutagenic activity of a novel polysaccharide isolated from Sepiella maindroni ink,” Food Chemistry, vol. 110, no. 4, pp. 807–813, 2008. View at Publisher · View at Google Scholar
  47. S. Koyanagi, N. Tanigawa, H. Nakagawa, S. Soeda, and H. Shimeno, “Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities,” Biochemical Pharmacology, vol. 65, no. 2, pp. 173–179, 2003. View at Publisher · View at Google Scholar
  48. J. Iida, K. L. Wilhelmson, J. Ng et al., “Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A),” Biochemical Journal, vol. 403, no. 3, pp. 553–563, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. N. Isnard, L. Robert, and G. Renard, “Effect of sulfated GAGs on the expression and activation of MMP-2 and MMP-9 in corneal and dermal explant cultures,” Cell Biology International, vol. 27, no. 9, pp. 779–784, 2003. View at Publisher · View at Google Scholar
  50. S. Sandya and P. R. Sudhakaran, “Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis,” Experimental Biology and Medicine, vol. 232, no. 5, pp. 629–637, 2007. View at Google Scholar
  51. M. Borgenström, A. Wärri, K. Hiilesvuo et al., “O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis,” Seminars in Thrombosis and Hemostasis, vol. 33, no. 5, pp. 547–556, 2007. View at Publisher · View at Google Scholar · View at PubMed
  52. S. Chen, J. Wang, C. Xue et al., “Sulfation of a squid ink polysaccharide and its inhibitory effect on tumor cell metastasis,” Carbohydrate Polymers, vol. 81, no. 3, pp. 560–566, 2010. View at Publisher · View at Google Scholar
  53. S. Rodríguez-Nieto, M. González-Iriarte, R. Carmona, R. Muñoz-Chápuli, M. A. Medina, and A. R. Quesada, “Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge,” The FASEB Journal, vol. 16, no. 2, pp. 261–263, 2002. View at Google Scholar
  54. R. G. Kerr and S. S. Kerr, “Marine natural products as therapeutic agents,” Expert Opinion on Therapeutic Patents, vol. 9, no. 9, pp. 1207–1222, 1999. View at Publisher · View at Google Scholar
  55. J. H. Jung, C. J. Sim, and C.-O. Lee, “Cytotoxic compounds from a two-sponge association,” Journal of Natural Products, vol. 58, no. 11, pp. 1722–1726, 1995. View at Publisher · View at Google Scholar
  56. J. S. Shim, H.-S. Lee, J. Shin, and H. J. Kwon, “Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro,” Cancer Letters, vol. 203, no. 2, pp. 163–169, 2004. View at Publisher · View at Google Scholar
  57. U. Staedt, H. Leweling, R. Gladisch, C. Kortsik, E. Hagmuller, and E. Holm, “Effects of ornithine aspartate on plasma ammonia and plasma and amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design,” Journal of Hepatology, vol. 19, no. 3, pp. 424–430, 1993. View at Google Scholar
  58. H. Tokuda, Y. Oiso, and O. Kozawa, “Protein kinase C activation amplifies prostaglandin F(2α)-induced prostaglandin E2 synthesis in osteoblast-like cells,” Journal of Cellular Biochemistry, vol. 48, no. 3, pp. 262–268, 1992. View at Google Scholar
  59. B. Ryu, Z.-J. Qian, and S.-K. Kim, “Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-κB activation, and induces human osteoblastic and chondrocytic differentiation,” Chemico-Biological Interactions, vol. 184, no. 3, pp. 413–422, 2010. View at Publisher · View at Google Scholar · View at PubMed
  60. C. Montagnani, F. Le Roux, F. Berthe, and J.-M. Escoubas, “Cg-TIMP, an inducible tissue inhibitor of metalloproteinase from the Pacific oyster Crassostrea gigas with a potential role in wound healing and defense mechanisms,” FEBS Letters, vol. 500, no. 1-2, pp. 64–70, 2001. View at Publisher · View at Google Scholar
  61. C.-S. Kong, J.-A. Kim, B. Ahn, H.-G. Byun, and S.-K. Kim, “Carboxymethylations of chitosan and chitin inhibit MMP expression and ROS scavenging in human fibrosarcoma cells,” Process Biochemistry, vol. 45, no. 2, pp. 179–186, 2010. View at Publisher · View at Google Scholar
  62. M.-M. Kim and S.-K. Kim, “Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts,” FEBS Letters, vol. 580, no. 11, pp. 2661–2666, 2006. View at Publisher · View at Google Scholar · View at PubMed
  63. N. Rajapakse, M.-M. Kim, E. Mendis, R. Huang, and S.-K. Kim, “Carboxylated chitooligosaccharides (CCOS) inhibitMMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1,” Biochimica et Biophysica Acta, vol. 1760, no. 12, pp. 1780–1788, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. A. S. Brito, D. S. Arimatéia, L. R. Souza et al., “Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp,” Bioorganic and Medicinal Chemistry, vol. 16, no. 21, pp. 9588–9595, 2008. View at Publisher · View at Google Scholar · View at PubMed
  65. J. L. Dreyfuss, C. V. Regatieri, M. A. Lima et al., “A heparin mimetic isolated from a marine shrimp suppresses neovascularization,” Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1828–1837, 2010. View at Google Scholar
  66. Y. Athukorala, G. N. Ahn, Y.-H. Jee et al., “Antiproliferative activity of sulfated polysaccharide isolated from an enzymatic digest of Ecklonia cava on the U-937 cell line,” Journal of Applied Phycology, vol. 21, no. 3, pp. 307–314, 2009. View at Publisher · View at Google Scholar
  67. J. Ye, Y. Li, K. Teruya et al., “Enzyme-digested fucoidan extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniae kylin inhibit invasion and angiogenesis of tumor cells,” Cytotechnology, vol. 47, no. 1–3, pp. 117–126, 2005. View at Publisher · View at Google Scholar · View at PubMed
  68. B. Ryu, Z.-J. Qian, M.-M. Kim, K. W. Nam, and S.-K. Kim, “Anti-photoaging activity and inhibition of matrix metalloproteinase (MMP) by marine red alga, Corallina pilulifera methanol extract,” Radiation Physics and Chemistry, vol. 78, no. 2, pp. 98–105, 2009. View at Publisher · View at Google Scholar
  69. Y. Fukuyama, M. Kodama, I. Miura et al., “Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga Ecklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors,” Chemical and Pharmaceutical Bulletin, vol. 37, no. 2, pp. 349–353, 1989. View at Google Scholar
  70. H. S. Kang, H. Y. Chung, J. H. Jung, B. W. Son, and J. S. Choi, “A new phlorotannin from the brown alga Ecklonia stolonifera,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 8, pp. 1012–1014, 2003. View at Google Scholar
  71. W.-K. Jung, S.-J. Heo, Y.-J. Jeon et al., “Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells,” Journal of Agricultural and Food Chemistry, vol. 57, no. 10, pp. 4439–4446, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Antioxidant properties of phenolic compounds,” Trends in Plant Science, vol. 2, no. 4, pp. 152–159, 1997. View at Publisher · View at Google Scholar
  73. I. Mook-Jung, H. Kim, W. Fan et al., “Neuroprotective effects of constituents of the Oriental crude drugs, Rhodiola sacra, R. sachalinensis and Tokaku-joki-to, against beta-amyloid toxicity, oxidative stress and apoptosis,” Biological and Pharmaceutical Bulletin, vol. 25, no. 8, pp. 1101–1104, 2002. View at Publisher · View at Google Scholar
  74. Y.-X. Li, Y. Li, S.-H. Lee, Z.-J. I. Qian, and S. E.-K. Kim, “Inhibitors of oxidation and matrix metalloproteinases, floridoside, and D-Lsofloridoslde from marine red alga laurencia undulata,” Journal of Agricultural and Food Chemistry, vol. 58, no. 1, pp. 578–586, 2010. View at Publisher · View at Google Scholar · View at PubMed
  75. M.-M. Kim, Q. V. Ta, E. Mendis et al., “Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity,” Life Sciences, vol. 79, no. 15, pp. 1436–1443, 2006. View at Publisher · View at Google Scholar · View at PubMed
  76. T. Mishima, J. Murata, M. Toyoshima et al., “Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis,” Clinical and Experimental Metastasis, vol. 16, no. 6, pp. 541–550, 1998. View at Publisher · View at Google Scholar
  77. L. Yang, Y. Wang, Q. Zhou et al., “Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization,” Molecular Vision, vol. 15, pp. 1951–1961, 2009. View at Google Scholar
  78. H.-M. Wang, J.-L. Pan, C.-Y. Chen et al., “Identification of anti-lung cancer extract from Chlorella vulgaris C-C by antioxidant property using supercritical carbon dioxide extraction,” Process Biochemistry, vol. 45, pp. 1865–1872, 2010. View at Publisher · View at Google Scholar